Training rhesus macaques to take daily oral antiretroviral therapy for preclinical evaluation of HIV prevention and treatment strategies.
<h4>Background</h4>Macaque models of simian or simian/human immunodeficiency virus (SIV or SHIV) infection are critical for the evaluation of antiretroviral (ARV)-based HIV treatment and prevention strategies. However, modelling human oral ARV administration is logistically challenging a...
Main Authors: | Michele B Daly, April M Clayton, Susan Ruone, James Mitchell, Chuong Dinh, Angela Holder, Julian Jolly, J Gerardo García-Lerma, James L Weed |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0225146 |
Similar Items
-
Limited SHIV <it>env</it> diversification in macaques failing oral antiretroviral pre-exposure prophylaxis
by: Zheng Qi, et al.
Published: (2012-05-01) -
Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
by: Hillary Claire Tunggal, et al.
Published: (2021-01-01) -
Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017-12-01) -
The Rhesus Macaque Corticospinal Connectome
by: Talmi, Sydney
Published: (2019) -
Neonatal imitation in rhesus macaques.
by: Pier F Ferrari, et al.
Published: (2006-09-01)